Skip to main content

GDU LC 2023 Main banner

Session 4: Debate: Alectinib vs Lorlatinib in ALK Positive

Session 4: Debate: Alectinib vs Lorlatinib in ALK Positive - Lorlatinib

Thursday, September 21, 2023

11:45 AM – 12:00 PM ET

Debate Speaker(s)

Misako Nagasaka, MD, PhD

University of California Irvine

Slides Slides